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ABSTRACT OF THESIS
ANORGANIC BOVINE HYDROXYAPATITE-PLGA COMPOSITES FOR BONE
TISSUE ENGINEERING
The objective of the present study was to synthesize porous, biodegradable poly (D, llactide-co-glycolide) PLGA-B-HA (Bovine hydroxyapatite) composite and evaluate the
effect of ceramic content on bone marrow cell differentiation in vitro. A macroporous
biodegradable PLGA-B-HA composite with the pore size varying from 0.1 to 1000µ and
a highly interconnected structure was fabricated using the freeze-drying/lyophilization
technique. A pilot study was done to determine the effects of B-HA on to the osteoblast
function. The main study was done to determine the effect of the increase in B-HA
concentration on to the mesenchymal stem cell differentiation. Morphological
characteristics of the composites were analyzed using FTIR and SEM/EDX analysis. The
composites were seeded with neonatal rat calvarial osteoblasts (NRCO). The polymer:
ceramic ratio in this study was 35%:65%. For comparison parallel experiments involving
pure HA-200 discs were performed. SEM results indicated a higher proliferation and
mineralization on PLGA-B-HA composites than pure HA discs. In addition, we evaluated
the in vitro characteristics of PLGA-B-HA composites with varying ratios, i.e., 1:1, 1:2
and 1:3, seeded with rat marrow cells. FTIR indicated an increase in the area under the
ceramic peak as ceramic concentration was increased. In addition, the average roughness
values increased in the order of 1:3 > 1:2 > 1:1. Both compressive strength and modulus
of 1:1 were significantly higher than 1:2 and 1:3 PLGA-B-HA composites. No significant
difference in compressive modulli and strengths could be observed for 1:2 and 1:3
PLGA-B-HA composites. Cellular activity was determined by measuring AP activity,
total protein analysis and osteocalcin concentration. Evaluation of alkaline phosphatase
activity showed bone cells attached to 1:3 (PLGA-B-HA) expressed significantly higher
alkaline phosphatase as compared to 1:1 and 1:2 PLGA-B-HA composites. In addition,
cells seeded on to 1:3 composites secreted significantly higher osteocalcin and at a
relatively short time period as compared to the other samples. Corrosion studies (ICP)
and pH values indicate minimal difference in the concentration of Ca and P and pH in
tissue culture media for all the samples at the end of all time periods. Hence we conclude
that an increase in the ceramic concentration stimulated mesenchymal stem cell
differentiation thereby promoting osteogenesis.
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CHAPTER ONE
INTRODUCTION

1.1 Motivation
Medical procedures relevant to bone related injuries prevalent in the United States with
over 800,000 grafting procedures are done annually [1]. 10% of the bone grafting
procedures include the use of synthetic graft substitutes. There is a need to develop
effective bone substitutes to heal large bone defects due to trauma; congenital disorders
etc. Autografts are tissues taken from the same patient. They are widely in the form of
cancellous autogenous bone or the gold standard [2]. They are osteogenic,
osteoconductive and osteoinductive. The presence of surviving cells, osteoinductive
proteins i.e. bone matrix proteins, mineralized matrix, and collagen supports cell
function. The limitations include donor site morbidity which includes pain, due to
grafting and limited availability of the donor organs. The procedure is expensive and may
be associated with post surgery complications.

Allografts on the other hand are bone graft substitutes that include tissue taken from a
different patient. The limitations include risk of infection during transplantation process.
It may also be accompanied with inflammatory reactions and in extreme cases leads to
graft rejection [2-4]. One case of hepatitis B transmission and 3 cases of hepatitis C
transmission have been reported with allograft tissue; the latest case occurred in 1992.
Cases involving HIV transmission have been reported in 2000 [2]. Xenografts include
transplantation of cells from different species. As with allografts, the major problem is
related with biocompatibility issues, humans have "natural antibodies" that circulate in
1

the blood and cause immediate graft rejection when organs from some species are
transplanted (for example grafts made from pig organs) [4].

Biomaterials based on polymers, ceramics, metals, bioactive glasses and composites
materials are used as synthetic bone graft substitutes [1-3, 5-7]. The limitations that
metals possess include extremely high mechanical properties than bone thereby leading
to stress shielding, subsequent weakening of the host tissue and making it susceptible to
fracture. The challenges currently include fabricating a biocompatible substrate that
provides a surface promoting direct bone apposition that ultimately acts as the true bone
tissue. Donor organ scarcity limits the number of people who require organ
transplantation. This problem has urged the development of a substrate that restores the
function of damaged tissue and enhances reconstruction using the tissue engineering
approach. The advantages of this technique include the elimination of repeated surgery at
the donor site.

The tissue engineered scaffolds must provide 3-dimensional tissue growth providing
optimal growth space and vascularization. In addition the scaffolds should be
biocompatible, highly porous and must have non-toxic degradation products. High
porosity provides sufficient space to promote cell infiltration within the scaffolds. The
viability of the cells would be maintained by vascularization. The cell viability is
hindered if the vascularization is improper which is dependent upon the interconnected
porous network structure of the scaffold [5].

2

1.2 Autologous transplants involving bone marrow stem cells
In an organism formation of bone takes place during the development of embryo, growth,
remodeling, fracture repair, and when induced experimentally for e.g. by purified or
recombinant members of the bone morphogenetic family (BMP). Bone marrow stroma
contains cells that have both proliferative and differentiative capacity. The differentiative
ability of the cells enables them to form multiple lineages, e.g. bone, cartilage, marrow
adipocytes, fibrous tissue and any other tissue in the body. This ability of unlimited and
extensive regenerative ability is due to regeneration of marrow stroma [8].

The mesenchymal stem cells differentiation into respective osteoblastic lineage or from
osteoblastic progenitors to an osteoblast starts with multipotential stem cells with an
unlimited regenerative capacity. The differentiation of multipotential stem cells leads to
the formation of progenitors for other mesenchymal cells including adipocytes,
fibroblasts and myoblasts as well as precursors for osteoblasts. They divide further to
form immature and then mature osteoprogenitors. At this stage these cells have limited
self regenerative capacity but high rate of proliferation. The mature progenitors
differentiate to form prosteoblasts which further differentiate into mature osteoblasts. The
mature osteoblasts divide post mitotically and give rise to osteocytes and eventually
leading to apoptosis. As the osteoblastic lineage progresses the cells have a limited rate of
proliferation but an extensive rate of differentiation. This continues till the cells
differentiate to form mature osteoblasts and which further differentiate to form osteocytes
[8].
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Variety of materials have been researched and incorporated to heal osseous defects.
These include autogenous and allogenic tissues [8-11]. While surgeons have extensively
used autograft to deliver osteoblasts to defect sites, the transplantation of in vitro
expanded osteoprogenitor cells is one of the current areas of focus in research today. In
vitro cultured human mesenchymal stem cells can synthesize collagenous and
noncollagenous proteins that are the components of skeletal matrix. A promising
approach involves the transplantation of human bone marrow stem cells (BMSC’s),
which have been shown to possess a high osteogenic potential. In order to make BMSC
transplantation useful as a method for forming new bone to close osseous defects in
patients, the technique must be improved to optimize the rate, extent of proliferation and
mechanical strength of the newly formed bone [8].

The development of a suitable matrix that permits the growth of the newly forming bone
or provides a surface that promotes direct bone apposition is a current focus of research.
A macroporous structure of the matrix permits extensive vascularization from the host
tissue and promotes cell viability and function. This further allows the transplant to be
incorporated in the defect region. This characteristic of the carrier matrix stimulates the
differentiation of mesenchymal stem cells to their specific osteoblast phenotype [9-10].

Osteogenic cells derived from rat bone marrow cells were cultured on polymeric twodimensional and three-dimensional tissue engineered scaffolds. The results indicated that
the scaffolds supported osteoblast function by the formation of a mineralized matrix
directly on the polymer surface. This bone-like apatite layer formed on the surface of the
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substrate promotes cell attachment and proliferation thereby allowing direct bone
bonding. The mineralized layer stimulates osteoblasts to secrete collagenous matrix [11].

1.3 Ideal Bone Graft substitute
The properties of an ideal bone graft substitute include simulating an autograft but
eliminating the problems associated with it. The scaffold when implanted within the body
should be biocompatible and bioresorbable with non-toxic degradation by products. It
should be composed of an osteoconductive matrix that mimics the calcified matrix of the
tissue and/or contains necessary bioactive factors to make it osteoconductive. This
includes autogenous osteoblast transplantation on to biodegradable, bioresorbable and
porous scaffolds. Porosity enables the infiltration of the cells deep within the scaffolds
and maintains cell viability by promoting vascularization. The transplanted cells may
secrete new matrix and factors necessary for bone ingrowth while the bioresorbable
material gradually degrades [9-11].

1.4 Types of Composites used as Bone substitutes
Composite materials have been widely used in bone reconstruction procedures. They
include polymer-ceramic composites, polymers composites of PLA, PGA, PLGA, PLLA,
PDLA, polyurethanes and polycaprolactones etc. or ceramic composites of calcium
phosphate series that include monocalcium and bi-calcium phosphates, α and βtricalcium phosphates, hydroxyapatite and bioactive glass composites etc. Polymers have
good mechanical strength but they lack osteoconductivity, on the other hand ceramics are
osteoconductive but are brittle [1-10, 26, 31, 42]. To address the limitations of individual
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materials, new materials based on composites of ceramics and polymers have been
proposed.

1.4.1 Polymers
1.4.1.1 Properties
Biodegradable polymers have been observed to support mesenchymal stem cell
differentiation and in cartilage regeneration [4-7]. Copolymers of two α-polyesters i.e.
polylactic acid (PLA) and polyglycolic acid (PGA) have been widely used to their
inherent biodegradable properties. They enhance bone remodeling by transferring
mechanical load to the surrounding tissues by virtue of degradation. They can be
completely resorbed within the body and can be eliminated by the normal metabolic
processes.

The degradation rates of copolymers could range from days to years by varying the ratio
of lactic acid to glycolic acid. Implants comprising of 100% PLA or 100% PGA degrade
at a slower rate than the copolymers due to their high crystallinity.

The polymer

degradation is due to hydrolysis. A crystalline morphology provides a definite structure
that restricts the penetration of water molecules thereby lowering the degradation rate.
Since the half life of PGA is shorter than that of PLA; hence increasing the PGA content
will enhance the degradation process. Other factors that influence the degradation rate
include viscosity and molecular weight of copolymers. Higher the molecular weight and
viscosity, slower would be the degradation as compared to low viscosity and low
molecular weight polymers [7].

6

1.4.1.2 Applications
1.4.1.2.1 Drug delivery
Biodegradable polymers such as poly (DL-lactide-co-glycolide) (PLGA) and polylactides
(PLA) are widely used for drug delivery due to their controlled degradation and
biocompatibility within the host tissues. [12]. In addition the major advantages of
biodegradable drug delivery systems involving hydrolyzing polymers is the elimination
of reoperation rates. The degradation by products are non toxic and can be eliminated by
the body easily which may not be the case for polymers like polyurethanes etc [12-13].

The distribution of the encapsulated drug within the polymeric phase would be influenced
by drug’s solid-state solubility and by the ability of the polymeric matrix to entrap drug
in dispersed state. An increase in the lactide content leads to the increase in
hydrophobicity and facilitates relatively higher solubility of a hydrophobic drug within
the hydrophobic phase. The release of drug is governed by its separation from the
polymeric phase and the surrounding aqueous environment. Higher the solubility of the
drug within the polymeric matrix, lower is the separation of the drug from the polymer to
the external aqueous phase. This results in lower rates of drug release. The drug release
from the biodegradable polymers i.e. PLGA/PLA polymers in the form of nano and
microparticles comprises of an initial controlled release phase followed by a slow release
period and a second release phase, which is characterized by the bulk degradation of the
polymer matrix [12, 14-15 ].
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1.4.1.2.2 In Bone regeneration
Several studies have shown use of PLGA as a scaffold to induce new bone tissue
formation [1, 3-11, 13, 17]. The advantages of using PLGA as a scaffold for bone
regeneration include 1) fabricated in different shapes; 2) the degradation time,
mechanical strength, and flexibility can be easily modulated by altering the copolymer
ratio; 3) even distribution of the cells throughout the scaffold thereby enhancing
osteogenesis throughout the system.

1.4.2 Calcium Phosphate ceramics
1.4.2.1 Properties
Calcium phosphate ceramics have been widely used in tissue engineering applications
due to the following reasons; a) they have a chemical composition similar to the
inorganic component of bone; b) have high CaO contents and have been reported to have
good bioactivity, and the osteoblasts can readily form mineral deposits on the surfaces of
CP’s in vitro and in vivo; c) induces the formation of bone like apatite layer thereby
providing direct bone bonding on to the surface unlike non bioactive materials. The
resorption rates of calcium phosphate ceramics have been studied widely. Resorption rate
of calcium phosphate ceramics depended on the form, chemical composition, porosity
(macro and micro), dissolution in the environment and cell mediated resorption. [16, 1821]. Resorption of calcium phosphates promoted bone formation [20, 25-26]. The free
Ca+2 ions released in the surrounding environment during the dissolution process have
been shown to induce bioactivity [22, 24-25].
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1.4.2.1.1 Comparison of resorption rates of the calcium phosphate ceramics on
osteogenesis
Dissolution and precipitation reactions occurring on the surface of calcium phosphate
ceramics leads to the formation of an apatite layer that would stimulate osteoblast
migration and function. Yuan et al. observed more bone ingrowth at the end of 150 days
within the porous β- TCP, whereas no bone in growth could be observed in the case of αTCP at the same time period [26]. Higher porosity facilitates dissolution/precipitation and
thereby mediating cell migration and function. Differences in bone formation could be
attributed to the differences in dissolution rates of the ceramics. β- TCP resorbs at a
slower rate as compared to α-TCP. But at longer time in vivo, β- TCP becomes more
resorbable. Dissolution/precipitation reactions at the ceramic-media interface results in
the formation of a bone-like apatite layer that promotes otseogenesis. Higher dissolution
of the ceramic for e.g. i.e. α-TCP could cause an increase in the local concentration of
Ca+2 and PO4

-3

thereby resulting in an increase in the local pH that may be unfavorable

to the surrounding environment. This may further hinder bone formation. Lower
dissolution of the ceramic reduces leads to decreased bioactivity as in the case of β –TCP
thereby hindering the already formed new bone on to the implant surface. Degradation of
ceramics could be altered depending upon the type and structure of the ceramic that is
being used thereby affecting the new bone formation.

9

1.4.2.1.2 Effect of varying porosity of calcium phosphate ceramics on osteogenesis
Effects of varying the sintering temperature onto the morphology of different ceramics
were studied. deGroot et al. investigated the influence of surface modifications on the
osteoconductive properties of two types of calcium phosphate ceramics (HA and β- TCP)
[31]. HA was sintered at 1150 and 12500 C. β- TCP consisted a blend of β- TCP and HA
was sintered at 1100, 1150 and 12000 C. The results indicated that changes in sintering
temperatures did not influence the ceramic chemistry and the blend composition.
Increasing the sintering temperature resulted in a decrease in microporosity with
macroporosity not being affected. An increase in microporosity within a macroporous
structure increases the specific surface area available for cell material interactions thereby
triggering the cells to differentiate into the osteoblastic phenotypes.

1.4.2.2 Applications
1.4.2.2.1 As cell-based carriers
Ti carriers have been used as because of their biocompatibility and excellent mechanical
properties [27-30]. Ti-fiber mesh implants and ceramic implants (60% HA and 40% αTCP) were incorporated with rat bone marrow stem cells and implanted subcutaneously.
New bone formation at the end of 1, 3 and 6 weeks in the case of ceramics grew up by
18% as compared to Ti-fiber meshes which grew up by 10%. Calcium phosphate
ceramics could be designed as a carrier system so as to deliver cells in the host site due to
significantly higher bone formation as compared to Ti implants.
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1.4.2.2.2 As a carrier of Bone morphogenetic protein
Calcium phosphate ceramics were investigated in vitro and in vivo as a delivery system
for bone morphogenetic proteins to induce bone formation in soft tissues. The
significance of BMP in calcium phosphate ceramics has been evaluated [32]. In vitro
experiments, studies have shown that BMP mixed with calcium phosphate ceramics can
induce rapid bone formation [33-34] and the bone formation was significantly higher than
that of BMP alone [33]. Enhancement of bone formation was seen in calcium phosphate
ceramics incorporated with b-BMP (Bovine-BMP). It was observed that the b-BMP from
the b-BMP solution in vitro was not only absorbed on to the calcium phosphate ceramics
and but it also adsorbed native BMP from in vivo fluids [32]. This shows a significant
role of BMP in calcium phosphate ceramics in osteoinduction. The native BMP
adsorption from the in vivo body fluids would induce osteogenesis by calcium phosphate
ceramics.

1.4.2.2.3 As a bone graft substitute in intervertebral spinal fusion
Calcium phosphate ceramic composites incorporated with mesenchymal stem cells
provide an alternative to autogenous graft materials for lumbar interbody spinal fusion.
Efficacy of bone marrow stem cells seeded on to calcium phosphate ceramics as bone
graft substitutes in a lumbar intervertebral spinal fusion process in rabbits were studied
[35].
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1.4.3 Polymer-Ceramic composites (Bone substitute composites)
1.4.3.1 Properties
The advantages of combining a biodegradable polymer (PLGA) with a ceramic (HA) are
used in tissue regeneration due to the following reasons, Improved mechanical properties
of the composite, enhanced osteoconductive properties of the polymer and due to the
buffering action on the acidic degradation byproducts from polyesters. Hydoxyapatite
ceramics are least soluble as compared to other CP ceramics. Due to its stability and
controlled degradation rate it could be used in vivo to give sufficient time to heal the
defect stimulating simultaneous degradation in a controlled manner [36-37, 41-45]. Bone
grafting materials may produce bone formation by osteogenesis, osteoinduction,
osteoconduction or osteotransduction. Osteogenesis is a process that includes provision
of osteogenic cells and matrix directly on to the graft; osteoinduction implies that the
chemotaxicity of the grafted material attracts the undifferentiated osteoprogenitor cells in
the host to the site of the graft and stimulates them to differentiate in to osteoblasts, e.g.
the use of bone morphogenetic protein; osteoconduction is a process that permits
outgrowth of osteogenic cells from existing bone surfaces into adjacent graft material e.g.
Calcium phosphate ceramics etc; and osteotransduction involves replacing a bone
substitute directly by bone [51].
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1.4.3.1.1 Effect of varying the pore size
Pore size is one major factor that controls the osteoblast proliferation or function in vitro.
For bone ingrowth, an optimum pore size of 200-400 microns has been observed. Pore
size 200-400 µm provides optimal compression and tension on the osteoblast’s
mechanoreceptors thereby promoting osteoblast function. This property stimulates
extracellular matrix secretion by the osteoblasts thereby inducing osteogenesis [36].

1.4.3.1.2 Mechanical properties
Mikos et al. studied hydroxyapatite reinforced poly (α-hydroxy ester) foams for bone
regeneration [37]. In this study low- and high-porosity composite foams PLGA and short
fiber hydroxyapatite ceramics were synthesized using the solvent casting particulate
leaching method. Incorporation of HA increased the compressive yield strengths of both
poly (α-hydroxy ester) foams [41-43].

1.4.3.2 Applications
1.4.3.2.1 As a carrier of bone morphogenetic protein
Polymer-ceramic composites were developed as carrier systems to deliver bioactive
molecules at targeted region to enhance osteogenesis [38-40]. Miki et al. evaluated
osteoinductive potential of PLGA/HA incorporated with BMP-2 in skull defects of rats.
Post implantation studies showed that the discs completely resorbed after 4 weeks and the
defect was filled with new bone. In contrast composites incorporated in defects without
BMP-2 were filled with fibrous connective tissue.
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1.4.3.2.2 In Bone regeneration
Besides their osteoconductive effect, ceramics have shown to neutralize the acidic
degradation products of PLA thereby improving the biocompatibility of the polymer [26,
31, 41-42]. Therefore their presence would be effective particularly during the
degradation of the polymer [41-42]. Most importantly in vitro culture studies showed
that cell survival percentage on the PLLA-HA (polymer-ceramic) scaffolds significantly
improved over the pure PLLA scaffolds. Calcium hydroxyapatite ceramics (CHA) are
nontoxic materials and cause minimal inflammatory reaction [44]. When the porous
composites were implanted into a rabbit femoral condyle, bone and bone marrow with
extensive vasculature formed deep in pores through the interpore connections. Excellent
interconnectivity enables osteoconduction thereby promoting cells and tissues to migrate
deep in to the pores.

1.5 Fabrication methods/Processing Methods for porous scaffolds
Various methods involving fabrication of low density porous polymeric scaffolds have
been synthesized by methods including solution casting/salt leaching, solvent evaporation
technique, freeze immersion, phase separation, gel casting, emulsion freeze drying, gas
foaming and fiber binding meshes. Solvent evaporation techniques typically produce
sacffolds exhibiting smaller pore sizes (1-20 µm). Solvent casting particulate leaching
method creates desirable pore size ranges by incorporation of the porogen; sieved NaCl
or soluble sugar particles of a desired size. The pore size and the porosity are determined
by the particle size and number of particles of the porogen within the polymer. However,
the significant loss of hydrophillic bioactive agents (e.g. drugs, antibiotics, growth factors
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incorporated into the foam during the fabrication process would occur during the leachout process [45-48].

1.5.1 Freeze drying/Lyophilization technique
1.5.1.1 Processing Parameters
Several studies have indicated the synthesis of macroporous scaffolds possessing a
desired pore range and interconnected porous network [47-49]. Processing parameters
included solvent composition, polymer concentration, freezing temperature, polymer type
and polymer molecular weight were optimized to arrive at a desired microstructure with
an interconnected network that would promote cellular growth and tissue integration.

As the freezing temperature increases, the nucleation rate increases and this results in the
formation of large number of small crystals of the solvent. And rapid evaporation of the
solvent leads to the formation of a microporous structure. Hence the microporosity can be
controlled by the quenching rate of the solvent. Also the solvent/non solvent ratio is also
an important determinant for obtaining a three-dimensional interconnected network.
Increasing the non solvent concentration leads to the formation of loose polymer
particulates with weak strengths were obtained. Porosity decreased by doubling the
polymer concentration. Very low polymer concentrations resulted in producing structures
with low mechanical strengths [47-49]. The porosity and density of the foams depend on
the molecular weight of the polymer chosen. Ma et al. showed that the density of the
PLGA-HA foams increased with the increase in the polymer to ceramic ratio [49]. At the
same time the porosity decreased as the polymer and the ceramic content were increased.
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As the polymer concentration was increased (2.5% to 7.5%), foams with thicker pore
walls and high mechanical strengths were obtained. As the polymer concentration was
decreased there was a suspension of the HA particles settled within the polymer particles
thereby forming a non-uniform solution [49].

1.5.1.2 Coarsening effect
Coarsening (coalescence of the phase separated droplets) continuously proceeds to reduce
the free energy associated with the interfacial area [50]. Macroporous scaffolds could be
obtained using the coarsening effect, which induces enlargement of the pores. The
coarsening time decreased with the increasing quenching temperature (temperature to
which the samples were exposed).

The coarsening effect was predominant in the core of the structures resulting in a
microporous structure than the surface thereby resulting in a macroporous surface.
Increasing the amount of water in the solvent mixture tended to generate large cellular
pores. This could be due to the fact that as the non solvent volume increases, a weaker
polymer-solvent interaction occurs which might induce the formation of poor phase with
greater solvent droplet domains. Increasing the quenching temperature induces the
coarsening effect thereby leading to the formation of enlarged pores with closed cellular
structures. As the amount of water incorporated into the solvent mixture was increased
closed cellular macropores upto 1000 µm were obtained [50].
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1.6 Objective/Purpose of the present study
The broad goal of this project is to synthesize porous resorbable bioactive B-HA-Polymer
composite that can be used as a tissue engineering scaffold to deliver bone marrow cells.
The objective of the present study is to synthesize a porous, biodegradable PLGA- B-HA
composite and evaluate the effect of ceramic content on bone marrow cell differentiation
in vitro. The synthesized macroporous polymer-ceramic scaffold with an interconnected
porous network eventually would enhance bone marrow stem proliferation and
differentiation in to osteoblastic phenotypes that can be used in treating bone defects.

We have used deproteinized bovine bone hydroxyapatite (B-HA) for the study. Studies
have shown that, it is a safe and a biocompatible bone graft material [53] and is of
osteoconductive nature [51, 53]. It is obtained from two different bone types, cortical and
cancellous bone and commercially available in two particle sizes 0.25-1 mm and 1-2 mm
[51]. The PLGA-B-HA composites were fabricated using the freeze drying/solid-liquid
phase separation technique. The study was done in order to determine the effect of
increase in ceramic concentration on osteoblast activity. Polymer used for the study is
Poly-D, L-lactide-co-glycolide (50:50) with a molecular weight 50-70,000 Da. This
polymer was chosen due to its controlled degradation 6 months- 1year. The polymers
can be tailored to degrade between weeks to years depending upon their copolymer ratio,
which can be used to balance the rate of osteoblast growth and ECM deposition on to the
degradation rate of the material.
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CHAPTER TWO
MATERIALS AND METHODS

2.1 Preparation of Polymer/Hydroxyapatite mixture
Deproteinized bovine hydroxyapatite (B-HA) was prepared and used for the study. The
structure of the B-HA was confirmed by X-ray diffraction analysis. Bovine
Hydroxyapatite (B-HA) particles were sifted in the size range (20 < x < 38) microns.
Poly (D, L-lactic-co-glycolic acid, lactide:glycolide ratio 50:50 (PLGA)

with IV

(Intrinsic viscosity) = 0.58 and Mw = 50,000-70,000 Da (Sigma, St. Louis, MO). The
scaffolds were prepared using the freeze drying/Lyophillization techniques. Bovine bone
was sintered at 10000 C to evaporate the organic material. After the evaporation of the
organic matrix, the residual matrix is the porous inorganic matrix which was used for the
study. The B-HA ceramic particles were first crushed and sifted to obtain the particle
range (20 < x < 38) µm. 0.73g of the polymer was mixed with 1.2g of sifted B-HA
particles in a 25 ml centrifuge tube followed by the addition of 8ml of chloroform. The
solution was allowed to stand for 24 hours for complete dissolution of the polymer. The
mixture was vortexed for 5-6 minutes till the polymer was dissolved completely so as to
obtain a uniform suspension of the ceramic particles within the polymer solution. The
mixture was transferred in to glass vials and stirred for 5 minutes using a magnetic stirrer
followed by drop wise addition of 2 ml of water. The solution was transferred in to
plastic moulds and placed in a dry ice container for 2 hours. The samples were in
specimen of 2 x 2 x 1.5 cm. They were stored in vacuum until use. A pilot study was
intended to test the effect of the ceramic (bovine hydroxyapatite) on osteoblast function.
From the results of the pilot study we designed the main study. The main study was
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designed to study the effect of increase in the ceramic concentration on bone marrow
stem cell differentiation.

The plastic moulds were lyophilized for about 24-48 hours to ensure complete
evaporation of the solvent. Similarly we initially weighed the polymer (1g) and ceramic
(1g) and mixed the two powders and prepared PLGA-B-HA composites (1:1, 1:2 and 1:3)
in a similar manner as described above. The samples were cut using a razor blade in the
dimensions of 12 x 11 x 2 mm. Prior freezing in liquid nitrogen was not done for this
study as it was understood that this mechanism could disrupt the morphological structure
of the composite.
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2.2 Cell isolation, seeding and culture
Fig. 1 Represents the isolation procedure of rat marrow stem cells.

Figure 1. The isolation technique of bone marrow stem cells from the femora of 7-week
old Fisher 344 male rats.
The two different types of cells that are used for this experiment were the neonatal rat
calvarial osteoblasts (NRCO) and bone marrow stem cells (BMSC’s). Neonatal rat
calvarial osteoblasts were isolated using a collagenase digestion technique. Two T-25
cm2 flasks containing 50 ml of PBS 50 and 34 µL of antibiotic respectively are taken.
Neonatal rat calvarial cells were isolated and cultured in the flask containing 50 µL of
antibiotic solution. The flask cap is then tightened and placed and in an ice box. Calvaria
from the brain tissue are cleaned in a sterile petridish and are made free from the extra
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tissue. The tissue is then transferred into 50 ml PBS solution prepared earlier. The PBS is
then pipetted out from the flask without disturbing the cleaned calvarial tissue. 5 ml of
collagenase-2 is added and is followed by the addition of 1 ml of trypsin. The flask cap is
tightened and stirred for 20 minutes and the solution is transferred in centrifuge tubes.
The tubes were centrifuged 400g for 10 minutes. The supernatant containing the enzyme
is transferred to the flask containing calvarial tissue and the cell pellet from the first
extraction is discarded. The second extraction was discarded and cells from subsequent
extractions were used for the experiment. For the third extraction the supernatant was
transferred in a tube and centrifuged at 400g for 10 minutes. The supernatant was
removed and 2 ml of media containing 10% Fetal Bovine Serum (FBS), 0.06%
fungizone, 0.1% antibiotic (penicillin) were added. The cell pellets are broken by
repeated pipetting and are further cultured in T-75 cm2 flasks in the incubator. The media
was changed after every 2-3 days. The cells were maintained in T-75 cm2 flasks. α
Minimally Essential Medium (αMEM) (Invitrogen Technologies, Grand Island, NY)
containing 10% Fetal Bovine Serum (FBS), 0.06% fungizone, 0.1% antibiotic (penicillin)
was used in vitro cell culture experiments.

The samples were initially sterilized in 70 % ethanol for 2 ½ hours. The cells were seeded
on to the scaffold giving a concentration of 50,000 cells/scaffold. The samples (positive
and negative control) were cultured in a 24-well plate immersed in 2 ml of media. The
other well plate consisted of pure HA (Interpore 200) seeded with NRCO immersed in
tissue culture medium. The cells were cultured for a period of 2 weeks and morphology
was analyzed using SEM/EDX. In the other study bone marrow stem cells were isolated
from the femora of 7-week old 344 Fisher male rats. Following euthanasia by CO2
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inhalation, the femurs were aseptically excised, cleaned of soft tissue, and washed in
αMinimally Essential Medium (αMEM) (Invitrogen Technologies, Grand Island, NY)
containing 10% fetal bovine serum (FBS), 0.06% fungizone, 0.1% antibiotic (penicillin)
and 3mM Na β-glycerophosphate (Sigma). Essential Medium (αMEM) containing the
above mentioned composition along with 50 µg/mL L-Ascorbic acid (Sigma) and 10-8 M
dexamethasone (Sigma) was used in vitro cell culture experiments. The metaphyseal ends
were then cut off and the marrow was flushed from the midshaft with 5-6 ml of media
using a syringe equipped with an 18 ½ G needle and collected in a sterile petridish. Cell
clumps were broken by repeatedly pipetting the cell suspension using 20 ½ G, 22 ½ G
and 23 G needles. The cells then were centrifuged at 500g for 5 min. The resulting cell
pellets were resuspended in 13 mL of media and plated in T-75 flasks (cells from two
femurs per flask). After 24 hours, hematopoietic cells and other unattached cells were
removed from the flasks. Once 70% confluency was reached the cells were enzymatically
lifted using 5-6 mL trypsin per flask. The cells were concentrated by centrifugation at
500g for 5 min and resuspended in 2 mL media. Cells were counted with a
hematocytometer in complete media [consisting of α- MEM supplemented with 10%
FBS, 3mM Na β-glycerophosphate, 50 µg/mL L-ascorbic acid (Sigma)] containing 10-8
M dexamethasone (Sigma) to promote the differentiation of bone marrow stromal cells to
osteoblastic phenotypes. Aliquots of cell suspensions were seeded onto the top of
prewetted foams placed in the wells of 24 well plates, resulting in seeding densities
equivalent to 250,000 cells/scaffold. The 24-well plate was left undisturbed in the sterile
hood for 6 min to allow the cells to attach after which an additional 2 ml of complete
media was added. Media was replaced after every 2-3 days. The control was used as a
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comparison for the alkaline phosphatase activity and for a qualitative assessment of the
mineralization.

2.3 Material Characterization
2.3.1 Fourier transform infrared spectroscopy Analysis (FTIR)
1:1, 1:2 and 1:3 PLGA-B-HA composites were analyzed using Fourier Transform
Infrared Spectroscopy. The data was collected using the Nexus 670 (Thermo Nicolet Inc)
using KBr as the background. The samples are placed within the sample holder and the
characteristic peaks are analyzed using the diffuse reflectance method.

2.3.2 Electron microscopy
PLGA-B-HA composites and pure HA discs seeded with and without cells were analyzed
using Scanning Electron Microscopy. Samples with cells are repeatedly washed with PBS
in a 24 well plate to remove the unattached substrates on to the surface. The samples are
placed in a fixative (10% formaldehyde or glutaraldehyde) and stored in the refrigerator.
Further they are dehydrated in ethanol series (50%, 60%, 70%, 80%, 90%, 95% and
100%). The samples were dehydrated in 50-70% for at least 5 minutes and 10 minutes for
the rest. The samples are then rinsed in Fluorotrichloromethane (Fereon) and coated with
gold palladium prior to SEM analysis. The SEM is a Hitachi Model S-3200-N with a
resolution of 3.5 nm. It is equipped with a Noran Energy Dispersive Spectroscopy {EDS}
system, which permits elemental analysis down to Boron. The Sputter Coater is a model
SC - 400 Emscope. The target material is AuPd. We sputter with argon at a pressure of
0.07 Torr for a period of one minute.
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2.3.3 Mechanical testing
The compressive mechanical properties of the composites were tested with a custom built
Compression testing machine (Center for Biomedical Engineering, University of
Kentucky, Lexington, KY). The displacement rate was set at 0.5 mm/min. At least 3
specimens were tested for each sample. The results were expressed as means ± standard
deviations.

2.3.4 Surface roughness characterization
2.3.4.1 Qualitative analysis of surface roughness
The ZYGO New View 5000 scanning white light interference microscope and scanning
electron microscopy were used to characterize surface roughness. A qualitative analysis
of the roughness was performed by scanning electron microscopy (SEM). The SEM is a
Hitachi Model S-3200-N with a resolution of 3.5 nm.

2.3.4.2 Quantitative analysis of surface roughness
Quantitative analysis of the roughness was performed by the ZYGO New View 5000
scanning white light interference microscope (ZYGO Corporation, Middlefield, CT,
U.S.A). The New View is a precision microscope which uses scanning white light
interferometry to generate quantitative three dimensional images. Zygo’s MetroPro

TM

software provides an interactive window display, surface images, plots and data. PLGAB-HA composites 1:1, 1:2 and 1:3 respectively were coated with aluminum. The PLGAB-HA composites were coated with aluminum using a sputtering machine (AJA
International, Kurt Lesker Inc.) with a coating time and thickness 230 seconds and 20 nm
respectively at 3 millitorr pressure. 10 readings representing approximately an area of 1 x
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200 µm were performed randomly corresponding to the different areas on the samples.
2.5X Mich (10X) were used with image zoom to measure the samples. Surface roughness
values were expressed as average roughness (Ra), root mean square roughness (Rrms)
and peak value (Rp). Rrms values give a good general description of the structure of the
actual surface. Ra is the arithmetic mean of the departures of the roughness profile from
the mean area.
(1)
Where Zi is the ith dot of the distance to the center line, n is the total number of sampling
dots, and Rrms, is the root mean-square deviation from the profile mean over the
sampling area, corresponding to Ra [54]:

(2)

PV (Peak-to valley) is the distance between the highest and the lowest points within the
sample [55-56]. In the current study Ra, Rrms and Rp values were calculated directly by
New View software.

2.4 Bioactivity Evaluation
2.4.1 Alkaline phosphatase assay
Production of alkaline phosphatase (ALPase) was measured spectroscopically.
Osteoblast-seeded foams and 2-D osteoblast cultures at the end of 10, 20 and 30 days
were washed with PBS and lysed using 1% Triton-X 100 (Aldrich Chemical Company
Incorporation) and the osteoblasts of the 2-D control cultures were scraped from the well
bottoms, using disposable cell scrapers, into 500 µL 1 % Triton-X 100. The sets were
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sonicated (FS 30, Fisher scientific incorporation) at 1300 rpm for 3min. The supernatant
was removed and transferred in new sets of micro tubes. The scaffolds were resuspended
in 500 µL 1 % Triton-X 100 and the same procedure was followed. The two supernatants
were combined and the resultant was used to measure the AP assay. The production of pnitrophenol in the presence of phosphatase substrate (Sigma, Inc.) was measured by
monitoring light absorbance by the solution at 410 nm at 5min increments. The slope of
the absorbance versus time plot was used to calculate the ALpase activity.

2.4.2 Osteocalcin
Bone marrow stem cells extracted from 7-week old Fisher 344 male rats were grown to
confluence (day 30) in culture medium. The medium was collected and stored at -20o C
until assay for osteocalcin. Osteocalcin concentration for 1:1, 1:2, 1:3 and control
samples was measured at the end of 14, 21 and 28 days respectively in tissue culture
medium. Determination of osteocalcin was performed in duplicate with an ELISA assay
(Biomedical Technologies Incorporation, MA, U.S.A); the detection range of the kit was
0.3-20 ng/ml.

2.5 Corrosion studies in tissue culture medium
The degradation rates were measured for 1:1, 1:2 and 1:3 PLGA-B-HA composites at the
end of 7, 14, 21 and 28 days by Optima 2000 DV used for ICP analysis. Four replicates
of each composition i.e. 64 samples in total were analyzed. pH measurements were taken
at the end of 28 days following immersion. The samples were diluted in 1:4 dilutions
using deionized water. The washing solution used in the experiment was 4% HNO3. The
samples were analyzed for Ca and P concentrations respectively.
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2.6 Statistical analysis
Two-way ANNOVA (assuming unequal variances) was performed to determine the
statistical significance (p < 0.05) in the mean value of measured parameters between the
different experimental groups.
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CHAPTER THREE
RESULTS

3.1 Pilot study
3.1.1 Characterization of the material
3.1.1.1 Surface morphology of PLGA-B-HA composite
SEM analysis indicated the external morphology of the PLGA-B-HA composite is highly
porous with the pore size varying from 30-1000 microns (Fig. 2). The arrows point to the
different pore sizes.

1mm
Figure 2. External morphology of the PLGA-B-HA composite. The SEM analysis
showed that the composite is highly porous with the pore size varying from 30-1000
microns. The arrows point to pores of various sizes.
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Higher magnification indicated that the inner walls of the composite were also porous
with the pore size varying from 20-1000 nm (Fig. 3). This indicates that the composite
has an open or an interconnected morphology. Also, we could observe a uniform
distribution of ceramic particles within the polymeric phase as indicated by the arrows.

10µm
Figure 3. Higher magnification of the wall of a pore as indicated in Figure 2. The inner
surface is also porous with the pore size varying from 20-1000 nm. The arrows indicate
the homogenous distribution of the ceramic particles and this is the surface where the
cells are getting attached to. From the figure we can draw a conclusion that the scaffold
acquired an open porous structure with an interconnected pore network.
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3.1.1.2 SEM analysis of the composite material
SEM analysis (Fig.4) shows the ceramic particles (arrows) were covering the surface of
the surface of the pores.

100µm
Figure 4.

SEM analysis of the PLGA-B-HA composite without cells. The figure

indicates the uniform distribution of the ceramic particles on the polymeric matrix. The
arrows point to B-HA particles.
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EDX analysis shows a Ca/P ratio of 1.67 (Fig.5). This ratio confirms the presence of the
HA ceramic incorporated in the polymer.

Figure 5. EDX analysis of PLGA-B-HA composite without cells. The Ca/P ratio in this
case is equal to be 1.67. The EDX analysis indicated the high Ca and P content indicating
that these are the ceramic particles.
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3.1.2 Cell adhesion and Morphology
3.1.2.1 Evaluation of pure HA discs (Interpore 200) seeded with neonatal rat
calvarial osteoblasts
SEM analysis after 2 weeks in culture showed neonatal rat calvarial osteoblasts attached
to the surface of the ceramic and formed unmineralized cell layer. Fig. 6 is an SEM
analysis of the cell layer demonstrating that the surface of the cell is smooth and void of
any calcified nodules. Beneath the non mineralized cell layer ‘C’, a dense collagenous
matrix is observed.

C
C

C

1mm
Figure 6. SEM image of the hydroxyapatite ceramic surface cultured with neonatal rat
calvarial cells for 2 weeks. The figure indicated the formation of a cell layer (c) with
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unmineralized extracellular matrix. It is worthy to note the absence of calcified nodules
on the cell surface. The arrows point out to the collagenous matrix beneath the cell layer.

At some places a network of collagen fibers could be observed (Fig. 7) whereas at some
places we could observe the fusion of the collagen fibers to form a dense layer of ECM.
An important thing to be noted here is the absence of calcified nodules or mineralized
matrix.

10µm
Figure 7. Neonatal rat calvarial cells cultured on to the surface of HA ceramic for 2
weeks. In some areas non mineralized collagen fibers were seen covering the surface and
forming a network. Collagenous fibers network fused together in some areas to make a
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continuous sheet of ECM on the ceramic surface. It is worth to note the complete absence
of calcified nodules.

3.1.2.2 Evaluation of PLGA-B-HA composites seeded with neonatal rat calvarial
osteoblasts
SEM analysis indicated (Fig.8) that neonatal rat calvarial osteoblasts attached to PLGAB-HA composites formed mineralized extra cellular matrix and calcified nodules after 2
weeks in culture.

10µm
Figure 8. Neonatal rat calvarial cells cultured on to PLGA-B-HA composites for 2
weeks. In contrast we could observe a dense mineralized, extracellular matrix formation
or calcified nodules on to the surface of the collagenous matrix. Calcified nodules are
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seen to be deposited on the surface of the collagen fibers as well as the bone like tissue.
Also at some areas we could observe interaction between the calcified nodules and the
collagenous fibers as indicated by the arrows. Mineralized extracellular matrix filled the
pores and covered the surface of the template.

Fig. 9 represents EDX analysis of the calcified nodules produced by the neonatal rat
calvarial cells cultured on PLGA-B-HA composites for 2 weeks. The Ca/P ratio as
indicated in the figure is equal to 1.66.

Figure 9. EDX analysis of the calcified nodules produced by the cells on the PLGA-BHA composite surface. The EDX analysis of the calcified nodules showed a Ca/P ratio of
1.66.
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Fig. 10 indicates the higher magnification of the calcified nodules. The arrows indicate
the immediate interaction between the calcified nodules and the collagen fibers. The
calcified nodules varied in the size range from 50-500 nm. Large numbers of calcified
nodules were seen covering the extracellular matrix (collagen fibers) in certain areas on
the composite surface.

5µm
HA
Figure 10. Higher magnification indicating the formation of a mineralized (ECM) layer
secreted by the cells seeded on to the PLGA-B-HA composite. In some places we can
observe accumulation of calcified nodules and the size of the nodules varied from 50-500
nm as indicated by the black arrows. Calcified nodules are seen to be deposited on the
surface of the collagen fibers as well as the bone like tissue. The white arrows point to the
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intimate interaction between the calcified nodules and the collagen fibers produced by
cells.
Also, we could observe the connection of pores via collagen fibers. The EDX analysis of
the calcified nodules confirms the secretion of inorganic bone mineral (hydroxyapatite)
by the cells with a Ca/P ratio equal to 1.67 (Fig.11).

Figure 11. EDX analysis of the interaction between the calcified nodules and the collagen
fibers secreted by the cells. EDX analyses indicated that the calcified nodules are
composed of mineralized hydroxyapatite with a Ca/P ratio equal to 1.67.
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A dense layer of calcified matrix could be observed within a crack in the pore wall of the
material (Fig. 12). Beneath the crack we could observe spherical shaped particles as
indicated by the white arrow. A significant difference could be observed in the
morphology of the particles secreted by the cells and the ceramic particles used in the
study. The ceramic particles are irregular shaped whereas the calcium phosphate particles
secreted by the cells are spherical in shape.

10µ
Figure 12. Indicating an area under the crack in the cell layer within the pore wall of
PLGA-B-HA composite seeded with cells. The figure describes the formation of a layer
of tissue within the area under a crack.
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Figure 13 indicates the EDX analysis of the area under the crack within the cell layer in a
pore. The EDX analysis indicates the Ca:P ratio of the cell layer to be 1.66 closer to the
inorganic component of bone.

Figure 13. EDX analysis of an area under a crack in the cell layer within the pore wall.
The EDX analysis indicates the high content of the Ca and P which indicates the cellular
activity. The Ca/P ratio in this case was equal to be 1.66 that indicates that the ratio is
close to the natural hydroxyapatite material.
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3.2 Main study
3.2.1 Effect of the chemical composition on the morphology of 1:1, 1:2 and 1:3
PLGA-B-HA composites
3.2.1.1 Qualitative analysis of surface roughness using SEM
Comparing the morphologies of 1:1, 1:2 and 1:3 we observe that the samples are highly
porous with the porosity varying from 40-1000 µ (Fig. 14, Fig. 15 and Fig. 16). 1:1
PLGA B-HA composite indicated the presence of comparatively thinner pore wall with
an average thickness of 85 µ. The pore walls are indicated by the black arrows (Fig. 14).

1mm
Figure 14. The figure shows the external morphology of 1:1 PLGA-B-HA composite.
The figure indicates the composite is highly porous with the pore size varying from 40 -

40

1000µ. The inner surface of the composite is also highly porous with the pore size
varying from 10-90 µ as indicated by the white arrows. The pore walls are significantly
(p < 0.05) thinner and are indicated by the black arrows. The average pore wall thickness
of the 1:1 PLGA-B-HA composite is equal to 85µ.
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Smaller pores as indicated by the red arrows within the pores with a pore size range
varying from 10-90 µ could be observed. The pore walls of 1:2 PLGA-B-HA composite
are thicker as compared to 1:1 PLGA-B-HA composites and are indicated by black
arrows (Fig. 15). The pore size varied in the range 60-1000 µ.Also, in 1:2 PLGA-B-HA
composite, smaller pores as indicated by the red arrows could be observed within the
pore walls of the larger pores. The smaller pores varied in the size range from 10-40 µ.
The average pore wall thickness of 1:2 PLGA-B-HA composite equals 130 µ

1mm
Figure 15. The figure shows the external morphology of 1:2 PLGA-B-HA composite.
The figure indicates that the composite is highly porous with the pore size varying from
60 - 1000µ. The inner surface of the composite is also highly porous with the pore size
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varying from 10-40 µ as indicated by the white arrows. The pore walls are significantly
(p < 0.05) thicker as compared to 1:1 PLGA-B-HA composites and are indicated by the
black arrows. The average pore wall thickness of the 1:2 PLGA-B-HA composite equals
130µ.
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Thicker pore walls could be observed in 1:3 as compared to 1:1 and 1:2 PLGA-B-HA
composites and are indicated by arrows (Fig. 16). The pore size varied in the range 301000 µ. The average pore wall thickness of the 1:3 PLGA-B-HA composite was equal to
182 µ. Also, here absence of smaller pores within the pore walls could be observed. The
composites appear to be rougher as compared to 1:1 and 1:2 PLGA-B-HA composites.
1:2 PLGA-B-HA composites appear to be rougher than 1:1 PLGA-B-HA composites.

1mm
Figure 16. The figure shows the external morphology of 1:3 PLGA-B-HA composite.
The figure indicates the composite is highly porous with the pore size varying from 30 1000µ. Here no inner pores could be observed as indicated by the white arrow. The pore
walls are significantly (p < 0.05) thicker as compared to 1:1 and 1:2 PLGA-B-HA
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composites and are indicated by the black arrows. The average pore wall thickness of
the1:3 PLGA-B-HA composite equals 182µ.

Table1. Indicates the average pore wall thickness of 1:1, 1:2 and 1:3 PLGA-B-HA
composites. The results indicate a significant increase in the pore wall thickness in the
order of 1:3 > 1:2 > 1:1 could be observed.

SAMPLES PORE

WALL

THICKNESS
1:1

85±29.155

1:2

130±49.22

1:3

182±57

p-VALUES

p-VALUES

p-VALUES

1:1 & 1:2

1:1 &1:3

1:2 & 1:3

0.025

0.00032

0.04

Table 1. Indicates average pore wall thickness of 1:1, 1:2 and 1:3 PLGA-B-HA
composites. The table also provides a statistical comparison of the average pore wall
thickness of the 1:1, 1:2 and 1:3 PLGA-B-HA composites.
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3.2.1.2 Quantitative analysis of surface roughness using the “New View 5000”
Quantitative analysis of surface roughness was done using the “New View 5000”
scanning white light interference microscope.

Figure17. Represents the surface of 1:1 PLGA-B-HA composite. The arrow indicates the
area to be scanned.

Figure 17. The color contour is represented by the micron scale and varies from -7.9 to +
18.7 µm. The positive value corresponds to the peaks whereas the negative value
corresponds to the valleys. The peaks are indicated by the green, yellow and red areas.
The valleys are indicated by the blue areas.
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Fig. 18, Fig.21 and Fig. 24 describes the oblique plots of randomly selected areas on 1:1,
1:2 and 1:3 PLGA-B-HA composites respectively. Fig.18. indicates the presence of peaks
indicated by the green lines. The scanning depth of the selected area varied from -1.46 to
+1.8 µm. Few peaks with increased heights up to 1.8 µm could be seen on the surface and
are indicated by red lines. The valleys are indicated by the blue lines.

Figure 18. The figure shows an oblique plot representing a randomly chosen area on 1:1
PLGA-B-HA composite. The selected area is marked as shown by the arrow (Fig. 17).
The thickness of the area varies from -1.46 to +1.8 µm. The negative sign indicates the
valleys and the positive sign indicates the presence of peaks on the surface. The red lines
indicate the presence of higher peak heights up to +1.8 µm and not too many peaks could
be observed here. Majority of the peaks are approximately of height 1.6 µm are indicated
by the green lines. The valleys correspond to the blue lines.
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Fig. 19, Fig. 22 and Fig. 25 indicate the 2-d profiles of the selected areas corresponding
to 1:1, 1:2 and 1:3 PLGA-B-HA composites. Fig. 19 shows the presence of narrower
peaks.

Figure 19. Figure indicates a 2-D profile of a randomly chosen area on 1:1 PLGA-B-HA
composite as indicated by the arrow (Fig. 17). The figure indicates the presence of
narrower peaks.
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Figure 20. Represents the surface of 1:2 PLGA-B-HA composite. The arrow indicates the
area to be scanned.

Figure 20. The color contour is represented by the micron scale and varies from -35.36 to
+ 25.43 µm. The positive value corresponds to the peaks whereas the negative value
corresponds to the valleys. The peaks are indicated by the green, yellow and red areas.
The valleys are indicated by the blue areas.
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Fig.21 indicates the presence of larger number of peaks with a considerable increase in
the peak heights ranging from -3.5 to +2.135 µ. Peaks are indicated by the green and red
lines. The blue lines correspond to the valleys.

Figure 21. The figure shows an oblique plot of a randomly chosen area on 1:2 PLGA-BHA composite. The selected area is marked as shown by the arrow (Fig.20). The
thickness of the selected area varies from -3.5 to +2.135 µm. The negative sign indicates
the valleys and the positive sign indicates the presence of peaks on the surface. Large
number of peaks with increased peak heights up to 2.135 µm could be observed on 1:2 as
compared to 1:1 PLGA-B-HA surface. The peaks are indicated by the red and green lines
whereas the valleys correspond to the blue lines.
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Fig. 22 showed an increase in the peak height and width as the ceramic concentration was
increased as compared to 1:1 PLGA-B-HA composites.

Figure 22. Figure indicates a 2-D profile of a randomly chosen area on 1:2 PLGA-B-HA
composite as indicated by the arrow (Fig. 20). As the ceramic concentration was
increased, an increase in the peak width and height up to 3.5 µm could be observed.
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Fig.23. represents the surface of 1:3 PLGA-B-HA composite. The arrow indicates the
area to be scanned.

Figure 23. The color contour is represented by the micron scale and varies from -39.5 to
+30 µm. The positive value corresponds to the peaks whereas the negative value
corresponds to the valleys. The peaks are indicated by the green, yellow and red areas.
The valleys are indicated by the blue areas.
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Fig.24 indicates An increase in the number of peaks with heights varying from -2.8 to
+2.065 µ and are indicated by the red, yellow and green lines on the 1:3 PLGA-B-HA
surface. The valleys are indicated by the blue lines.

Figure 24. The figure shows an oblique plot of a randomly chosen area corresponding to
1:3 PLGA-B-HA composite. The selected area is marked as shown by the arrow (Fig.
23). The thickness of the selected area varies from -2.8 to +2.065 µm. The negative sign
indicates the valleys and the positive sign indicates the presence of peaks on the surface.
Here larger number of peaks with increased peak heights up to 2.065 µ could be
observed. The surface appears to be rougher due to the increase in the number of peaks as
compared to 1:1 and 1:2 PLGA-B-HA composites. The peaks are indicated by the red
yellow and green lines. The valleys correspond to the blue lines.
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Fig. 25 indicates a considerable increase in the peak heights and widths in case of 1:3
PLGA-B-HA composites.

Figure 25. Figure indicates a 2-D profile of a randomly chosen area on 1:3 PLGA-B-HA
composite as indicated by the arrow (Fig. 23). As the ceramic concentration is further
increased a significant increase (p < 0.05) in the peak width and height up to 4 µm could
be observed. After a certain scanning length i.e. between 30- 50 µ not many valleys could
be observed.

54

The results indicate significantly higher (p < 0.05) average (Ra) values of roughness for
1:3 as compared to1:1 and 1:2 PLGA-B-HA composites (Table 2). The Ra values
increased in the order 1:3 > 1:2 > 1:1.

SAMPLES

Ra (µM)

Rrms (µM)

SAMPLE

p-Ra

p-Rrms

COMPARISON
1:1

5.022±3.364

6.77±4.406

1:1 &1:2

0.007

0.007

1:2

10.11±2.851

13.641±3.5

1:1&1:3

0.00024

0.00024

1:3

13.6±1.762

17.145±2.14

1:2 &1:3

0.0032

0.0032

Table 2. Indicates average roughness values of 1:1, 1:2 and 1:3 PLGA-B-HA composites
respectively. The table also provides the statistical comparison of the average roughness
values of 1:1, 1:2 and 1:3 PLGA-B-HA composites.
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3.2.2 FTIR analysis

Figure 26. FTIR spectra of 1:1. 1:2 and 1:3 PLGA-B-HA composites. The functional
groups corresponding to the polymer (PLGA) and ceramic (HA) are indicated in Table 3.
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Table. 3 summarizes the IR bands corresponding to the polymer and the ceramic
respectively. The areas under the ceramic and polymer peaks were analyzed and
compared for 1:1, 1:2 and 1:3 PLGA-B-HA composites.

IR BANDS

ASSIGNMENTS

IR BANDS (cm-1)

(cm-1) (PLGA)

ASSIGNMENTS

(HA)

1453

C-H(CH3) groups

1090,1042

P-O(PO4) groups

1348,1388

C-H(CH3) groups

962

P-O (PO4) groups

1269

C-H and C-O

872

P-OH (HPO4) groups

1189

C-O

627

O-H (OH) group

602,567

P-O(PO4) groups

471

P-O(PO4) groups

Table 3. Infrared vibrational frequencies of PLGA and HA in the 2000-1000 cm-1 and
2000-400 cm-1 region.
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3.2.3 Mechanical testing
Table 4 summarizes the compressive modulus and failure strain of 1:1, 1:2 and 1:3
PLGA-B-HA composites respectively. The table also provides a comparison of
compressive strengths and modulli of PLGA-PCL-HA, PLGA-HA and PLGA-PCL
composites with trabecular bone. Both, the compressive modulus and compressive yield
strength of 1:1 are significantly higher (n = 3, p < 0.05) than those of 1:2 and 1:3 PLGAB-HA composites respectively. Compressive strength and compressive modulus of 1:2
are significantly higher (p < 0.05) than 1:3 PLGA-B-HA composites.
POLYMER-CERAMIC

COMPRESSIVE FAILURE

COMPRESSIVE

COMPOSITES

STRENGTH

STRAIN

MODULUS

1:1

0.36±0.055

0.145±0.0035 2.5±0.32

1:2

0.07±0.026

0.16±0.007

0.42±0.15

1:3

0.045±0.02

0.15±0.013

0.3±0.12

Table 4. The compressive modulus and yield strength of 1:1, 1:2 and 1:3 PLGA-B-HA
composites prepared from the freeze drying lyophillization technique.
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3.2.4 Biochemical Assays
3.2.4.1 Total protein analysis
Minimal difference (n = 4, p > 0.05) in the protein concentration secreted by the bone
marrow stem cells on to 1:1, 1:2 and 1:3 PLGA-B-HA composites could be observed at
the end of 10 and 30 days (Fig. 27). At the end of 20 days cells attached to the surface of
1:2 and 1:3 PLGA-B-HA composites produced significantly (p < 0.05) higher protein
concentration (µg/ml) as compared to

1:1 PLGA-B-HA composites. No significant

difference (p > 0.05) in the protein concentration produced by the cells cultured on to 1:2
and 1:3 PLGA-B-HA composites at the end of 20 days could be observed.

Figure 27. Indicates the concentration of the protein in µg/ml produced by the rat marrow
cells cultured on to 1:1, 1:2 and 1:3 PLGA-B-HA composites at 10, 20 and 30 days
respectively. The results show no significant difference in the protein concentration
(µg/ml) produced by the cells cultured on to 1:1, 1:2 and 1:3 PLGA-B-HA composites at
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the end of 10 days. At the end of 20 days, cells cultured on to 1:2 and 1:3 PLGA-B-HA
surfaces produced significantly higher ( n = 4, p < 0.05) protein as compared to 1:1
PLGA-B-HA surfaces. No significant difference (p > 0.05) in the protein concentration
produced by the cells cultured on 1:2 and 1:3 PLGA-B-HA composites at the end of 20
days could be observed. At the end of 30 days no significant difference (p > 0.05) in the
protein concentration produced by the cells cultured on 1:1, 1:2 and 1:3 PLGA-B-HA
composites could be observed.
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3.2.4.2 Alkaline phosphatase assay
Fig. 28 shows the AP activity in nmol of pNP/min/µg protein and protein concentrations
produced by rat marrow cells cultured on to 1:1, 1:2 and 1:3 PLGA-B-HA composites for
a period of 10, 20 and 30 days respectively. The results of the 10 and 20-day experiment
indicated no significant difference (n = 4, p > 0.05) in the AP activities on 1:1, 1:2 and
1:3 PLGA-B-HA composites respectively. The results of the 30-day experiment indicated
the bone marrow stem cells expressed significantly higher alkaline phosphatase (n = 4, p
< 0.05) on 1:3 as compared to 1:1 and 1:2

PLGA-B-HA composites. No significant

difference (p > 0.05) could be observed in the alkaline phosphatase activities of rat
marrow stem cells on to 1:1 and 1:2 PLGA-B-HA composites at the end of 30 days
respectively.

Figure 28. AP activity in nmol of pNP/min/µg protein produced by rat marrow stem cells
on 1:1, 1:2 and 1:3 PLGA-B-HA composites at the end of 10, 20 and 30 days. The figure
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represents the AP activity (nmol of pNP/min/µg protein) and protein concentrations
(µg/ml) produced by rat marrow cells cultured on to 1:1, 1:2 and 1:3 PLGA-B-HA
composites at the end of 10, 20 and 30 days respectively. At the end of 10 days, no
significant difference ( n = 4, p > 0.05) could be observed in the AP activity and protein
concentrations on 1:1, 1:2 and 1:3 PLGA-B-HA composites. At the end of 20 days, no
significant difference (p > 0.05) in AP activity produced by the cells on 1:1, 1:2 and 1:3
PLGA-B-HA composites could be observed. At the end of 30 days cells expressed
significantly (p < 0.05) higher AP on 1:3 as compared to 1:1 and 1:2 PLGA-B-HA
composites.
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3.2.4.3Osteocalcin
Osteocalcin concentration in absorbance units of 1:1, 1:2 and 1:3 PLGA-B-HA
composites and control samples were measured at the end of 14, 21 and 28 days
respectively. The results indicated bone marrow stem cells seeded on to the 1:3 PLGA-BHA composites expressed significantly higher ( n =3, p < 0.05) osteocalcin at the end of
14 and 21 days respectively. 1:2 expressed significantly higher (p < 0.05) osteocalcin
secretion by osteoblasts at the end of 28 days as compared to 1:1 PLGA-B-HA
composites and 1:3 PLGA-B-HA composites. Cells seeded on to the 1:1 PLGA-B-HA
composites produced significantly lower (p < 0.05) osteocalcin as compared to 1:2 and
1:3 PLGA-B-HA composites at the end of 28 days respectively (Fig. 29).

Figure 29. Osteocalcin concentration in absorbance units of 1:1, 1:2, 1:3 PLGA-B-HA
composites and control samples at the end of 14, 21 and 28 days respectively.
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3.2.5 Corrosion studies in tissue culture medium
3.2.5.1 Ca concentration at the end of 28 days
ICP analysis showed minimal difference ( n = 4, p > 0.05) in the Ca concentrations of
the tissue culture media incubated with or without various PLGA-B-HA samples at the
end 7, 14, 21 and 28 days (Fig. 30).

Figure 30. ICP measurements of Ca concentrations in the media incubated with PLGAB-HA composites (1:1, 1:2, 1:3) and control samples incubated in polystyrene culture
dishes for 7, 14, 21 and 28 days respectively in the presence of bone marrow stem cells.
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3.2.5.2 P concentration at the end of 28 days
ICP analysis showed minimal difference ( n = 4, p > 0.05) in the P concentrations
between the PLGA-B-HA composites and cells incubated in polystyrene dishes at the end
7, 14, 21 and 28 days respectively (Fig.31)

Figure 31. ICP measurements of p concentrations in the media incubated with PLGAB-HA composites (1:1, 1:2, 1:3) and control samples incubated in polystyrene culture
dishes for 7, 14, 21 and 28 days respectively in the presence of bone marrow stem cells.
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3.2.6 pH measurements at the end of 28 days
pH values of 1:1, 1:2, 1:3 PLGA-B-HA composites and control samples incubated in
polystyrene dishes in the presence of bone marrow stem cells at the end of 7, 14, 21 and
28 days respectively were measured. Results indicate a minimal difference (p > 0.05) in
the pH values of the composites and cells incubated in polystyrene dishes in tissue culture
medium at the end of 28 days (Table 5).

COMPOSITIONS

MEAN ±

COMPOSITIONS

MEAN ±

21ST DAY

STDV.

28TH DAY

STDV.

21ST DAY

28TH DAY

1:1

7.67 ± 0.06

1:1

7.5 ± 0.051

1:2

7.7 ± 0.042

1:2

7.54 ± 0.042

1:3

7.6 ± 0.1

1:3

7.62 ± 0.07

CONTROL

7.7 ± 0.14

CONTROL

7.33 ± 0.053

Table 5. pH values of the tissue culture media containing 1:1, 1:2, 1:3 PLGA-B-HA
composites and control samples incubated in polystyrene dishes at the end of 21 and 28
days respectively.
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CHAPTER FOUR

DISCUSSION
4.1 Pilot study
4.1.1 Significance of Bovine bone hydroxyapatite
To engineer an ideal scaffold has prompted us to synthesize a macroporous polymerceramic composite with an appropriate ratio of the bioresorbable polymer to the bioactive
ceramic that could enhance osteoblast function. In our study we have employed porous
bovine hydroxyapatite to synthesize the polymer-ceramic composite.

4.1.2 Significance of the copolymer ratio
The polymer used in the study was PLGA 50:50; Mw = 72000Da. The polymer was
chosen due to controlled degradation and good mechanical properties. Degradation rate
of the polymer can be controlled by altering the copolymer ratio and the molecular
weights. Below a molecular weight of 10,000, PLGA foams had very little mechanical
strength [57].

4.1.3 Significance of Freeze-drying technique
The PLGA-BHA composite synthesized using the Freeze-drying lyophilization technique
[43-46, 57-60] allowed for highly porous structure with a pore size varying from 40-1000
µm as indicated by the arrows in (Fig. 1). In this procedure, two phases- a polymer-rich
phase and a polymer-lean phase are formed by cooling down the polymer solution
thereby inducing a liquid-liquid phase separation. The solvent is then extracted by
placing it in a vacuum chamber and the solvent removal leads to the formation of the
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macropores. Chloroform was preferred instead of dioxane due to its lower freezing
temperature. As the ceramic concentration was increased, foams synthesized using
dioxane as a solvent were rigid and microporous. The optimal pore size for bone grafting
is in the range of 100-350 µm [43]. The PLGA-BHA material prepared in the present
study satisfies most the requirement of the ideal pore size for osteoblasts infiltration,
viability and function. SEM analyses indicated that PLGA-composite is marcoporous and
had interconnected open pore morphology. SEM (Fig 7.) analysis indicated that neonatal
rat calvaria osteoblasts attached to the surface of PLGA-B-HA. Also the composite is
highly porous with the porosity varying from 30-1000 µ. This matches the requirement of
the ideal pore size required for the promoting osteoblast viability and function.

4.1.4 Significance of cell-material interactions
Cell adhesion is an important aspect of cell interaction with a biomaterial since it is
required for cell proliferation, differentiation and cell spreading on to the material
surface. Cell adhesion and spreading are two distinct phenomenon’s because it has been
shown that the substrates that allow cell adhesion do not necessarily promote cell
spreading. The initial osteoblast/material interactions are characterized by four stages: (1)
protein adsorption to the surface, (2) contact of cells with the surface, (3) cell attachment
and (4) cell spreading. The 90-min time would reflect the interactions involving the first
contact of the cell with the substrate followed by the attachment on the substrate. Initial
spreading occurs at the end of 4h which is characterized by reorganization of the
cytoskeletal matrix and flattening of the cell. At the end of 24 hours the cells are expected
to be flat and spread and to have started proliferating. There are no fixed time periods that
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characterize the cell morphology as the cell morphology changes with the type of the
substrate and also the type of the cell used [61].

After attachment to the PLGA-BHA the cells produced extensive mineralized ECM at the
end of 2 weeks. The EDX ratio (Fig. 8, Fig. 10 and Fig. 12) indicates the presence of
biological HA with the Ca/P ratio equal to 1.66. On the other hand (Fig. 5) indicated the
cells on HA discs produced collagenous matrix. Also in some areas we could observe the
collagen fibers merging to form a continuous sheet of ECM (Fig. 6). However, no
inorganic matrix was produced by the cells attached to HA which could be seen by the
absence of calcified nodules.

While the HA discs stimulated the formation of un

mineralized organic matrix, the PLGA-B-HA composites stimulated both the formation
of organic as well as the inorganic matrix. This could be seen by the presence of calcified
nodules (Fig. 7 and Fig. 9). Cells appear to be somewhat flat when cultured on to the
surface of PLGA/PCL/HA composites at the end of 2 weeks [62].

However in our study we observed comparatively extensive mineral secretion by
neonatal rat calvarial osteoblasts cultured on to PLGA-B-HA composites at the end of 2
weeks. The results of the pilot study indicated higher cellular activity on PLGA-B-HA
composites as compared to pure HA discs. Higher osteoconductivity of B-HA is due to
the similar mineral content or inorganic portion of the ceramic as that of the bone. Even
though the inorganic component of Interpore 200 is similar to that of the inorganic
portion of natural bone, the porosity when compared to B-HA is different. We have
evaporated the organic component from the bovine bone thereby leading to the formation

69

of a porous structure. The porosity of the ceramic (B-HA) provides larger surface area
thereby increasing cell attachment, facilitating cell infiltration and extracellular formation
as observed from the SEM (Fig. 8 and Fig. 10). .

Hence the results of the pilot study have prompted us to further expand and evaluate the
effect of varying the ceramic concentration on the stimulation of osteoblastic activity.

4.2 Main study
4.2.1 Significance of surface topography
Surface modification of biomaterials has been one of the major factors in the
development of tissue engineering. As a scaffold, the significance of biomaterials is that
they can not only interact with the cells but also with the host environment, through the
interface. Immobilization of bioactive molecules on the surface of the substrate would
mediate cell behavior. Such differences in topographies contribute to the changes in
hydrophobicity/hydrophilicity balance. On the other hand, such differences also led to the
differences in deposition of serum proteins. It is generally known that the
hydrophobicity/hydrophilicity of a film surface can affect the degree of cell adhesion and
proliferation. Hydrophilicity is a factor affecting surface energy, which might influence
serum proteins that adhered to these materials and in turn influence cell proliferation and
differentiation [61]. It has been observed that the topography of a porous surface
enhances migration by physically directing tissue movement [62].
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Lactic acid is more hydrophobic than glycolic acid, and increase in its concentrations
increases hydrophobicity. An increase in hydrophobicity corresponds to the decrease in
degradability. PLGA is amorphous in nature and hence the copolymer matrices degrade
at a relatively high rate. An increase in PLA or PGA content in PLGA will increase the
crystallinity of the polymer and hence the degradation time [64]. Migration of the cells on
to the porous surface was dependent on the surface chemistry. It has also been reported
that hydrophilic surfaces exhibit greater cellular adhesion over hydrophobic surfaces [6466]. Sato et al. showed exposure of HA and/or TiO2 particles in PLGA+TiO2
precursor+HA coatings after decomposition of PLGA due to hydrolysis increased coating
hydrophilicity [67]. Also it has been reported that surface roughness leads to an increase
in adhesion of bone forming cells, indicating the remodeling activity [67-72]. Schwartz et
al. studied that the microrough topography of titanium implants exhibited increased pull
out strength in vivo suggesting increased implant-tissue adhesion. In vitro studies further
revealed that as the surface microroughness is increased, osteoblast proliferation is
decreased whereas differentiation is increased [72]. Anselme et al. qualitatively evaluated
the adhesion of human osteoblasts on orthopedic metallic substrates with various surface
roughnesses and its correlation with qualitative changes in the expression of adhesive
proteins and with parameters describing the surface topographies [73]. It was shown that
the cell layer organization was modified by the roughness of the material surfaces thereby
initiating cell differentiation [73-75].

71

4.2.2 Effect of the chemical composition on the morphology of 1:1, 1:2
and 1:3 PLGA-B-HA composites
4.2.2.1 Surface roughness characterization
4.2.2.1.1 Qualitative analysis of surface roughness
Fabrication parameters such as ceramic to polymer concentration and water to solvent
ratio were varied to arrive at reproducible targeted macroporous structures. From the
SEM we can clearly observe a difference in the pore wall thickness and porosity in case
of 1:1, 1:2 and 1:3 PLGA-B-HA composites (Fig. 13, Fig. 14 and Fig. 15). A significant
increase (p < 0.05) in the pore wall thickness in the order of 1:3 > 1:2 > 1:1 could be
observed (Table 1). The thicker pore walls of 1:3 PLGA-B-HA may be due to the higher
concentration of the ceramic. There might be due to the ceramic particles that are loosely
adhered on to the pore walls of the composite. We could observe an increase in ceramic
concentration decreases the porosity as observed in case of 1:3 PLGA-B-HA composites.
This is due to the decrease in the volume of the solvent due to the increase in ceramic
concentration.

4.2.2.1.2 Quantitative analysis of surface roughness
Characterization of the changes in surface topography was done using the “New View
5000” scanning white light interference microscope. For analyzing the changes in surface
topography the sample surface has to be extremely reflective. Specific regions within a
reflective surface are selected and are converted to corresponding data points thereby
creating an image which is eventually displayed on a computer screen. Certain areas were
selected on the surface of 1:1, 1:2 and 1:3 polymer-ceramic composites respectively (Fig.
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16, Fig. 19 and Fig. 22) and by a command called ‘MASK’ we highlighted the specific
areas and captured the 2-D and 3-D profiles respectively. We have analyzed 10 different
areas on the pore walls of different compositions (1:1, 1:2 and 1:3 respectively) and
computed the average, rms and peak roughness values. The average, peak and the rms
values varies position by position on the sample surface indicating a change in the
topography.

The results indicate that the average roughness values (µm) in the order of 1:3 > 1:2 >
1:1. Table 1. indicates a significant increase (n = 3, p < 0.05) in the pore wall thickness in
the order of 1:3 > 1:2 > 1:2 PLGA-B-HA composites. Fig. 17, Fig. 20 and Fig. 23
indicate an oblique plot of a specific area (Fig. 16, Fig. 19 and Fig. 22) on 1:1, 1:2 and
1:3 PLGA-B-HA composites respectively. The peaks are indicated by the red and the
green lines whereas the valleys are indicated by the blue lines. As the concentration of the
ceramic is increased an increase in the area under the peak is observed. The scanning
depth on the surface was 50 µm. The maximum peak height from the line profile for 1:1
was 1 µm, whereas for 1:2 and 1:3 it was 3.4 and 4 µm respectively. As the concentration
of the ceramic is increased due to deposition of ceramic on to the surface, the height of
the peak is increased as seen by the 2-D profile with an increase in the width (Fig. 18,
Fig. 21, and Fig. 24). The increased width represents the increased ceramic concentration
thereby covering some valleys.

Pore wall roughness indicates a variation in surface topography. Higher variation in
topography gives a higher peak to valley value. Also higher Ra value indicates higher
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roughness. 2-D profiles quantify the roughness and compare the changes in topography
on different areas within the same sample as well within different samples. 1:1 represents
a comparatively smoother surface indicating lesser magnitude of the peak to valley
distance. 1:2 indicates a significantly higher peak to valley distance indicating a bumpier
surface as compared to 1:1. When analysis was done on 1:3 PLGA-B-HA composite it
showed significantly higher (p < 0.05) roughness as compared to 1:2 and 1:1 PLGA-BHA composites respectively. The surface roughness was increased due to the ceramic
concentration. Ceramic (B-HA) is rough in nature and an increase in ceramic
concentration led an increase in surface roughness. Niederauer et al. showed that surface
roughness, for osteoceramic materials, improved surface wetting properties [76]. This can
further promote cell adhesion on to the biomaterial via formation of focal contacts or
indirectly through selective adsorption of osteoinductive proteins favoring cell adhesion.
The surface energy of hydroxyapatite significantly influences cell adhesion and spreading
of human osteoblastic cells at the surface [77]. Hence an increase in hydroxyapatite
concentration is indicated by the increase in the surface roughness. An increase in surface
roughness contributes to the increase in the surface area thereby favoring cellular
attachment.
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4.2.3 FTIR analysis
Table 3 indicates the characteristic peaks in the region 1500-1000cm-1 and 1000-400 cm-1
for the polymer and hydroxyapatite respectively [78]. FTIR analysis indicated the
presence of the ceramic phase as observed by the characteristic bands of PLGA and HA
(Fig. 25). An increase in the area under the ceramic phase could be observed in case of
1:3 as compared to 1:1 and 1:2 PLGA-B-HA composites.

The results indicate an increase in the ceramic concentration, increases the area under the
ceramic peak thereby increasing the ratio of the area measured under the ceramic to
polymer (Fig. 25). The IR bands corresponding to the ceramic peaks are located at 567,
602 cm-1 and 962 cm-1, representing the P-O (PO4) groups and 627 cm-1 representing the
O-H groups respectively. The IR bands corresponding to the polymer peaks are located at
1453 cm-1 representing C-H (CH3), C-H and at 1269 cm-1 corresponding to C-O groups
respectively. In the above study we have incorporated PLGA in to B-HA to modify the
degradation as well as to improve the mechanical properties of the composite

4.2.4 Mechanical testing
For mechanical testing 3 samples were tested for each composition. The samples were
tested under compression. It was observed that the compressive strength and modulus of
1:1 were significantly higher than those of 1:2 and 1:3 PLGA-B-HA composites. The
polymer-ceramic composite is synthesized using the freeze drying/lyophilization
technique. The polymer in this case forms a supporting matrix to which the ceramic
particles adhere. An increase in the ceramic concentration or a decrease in the polymer
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concentration gives rise to loosely attached ceramic particles. The particles are loosely
bounded and have a tendency to shed off from the surface of the composite. For 1:2 and
1:3 PLGA-B-HA composites significant leaching of the ceramic particles could be
observed. Hence this lowers the ceramic concentration and as the polymer concentration
is less as compared to 1:1 PLGA-B-HA composites, we could observe a significant
decrease in the compressive strengths and modulli of 1:2 and 1:3 PLGA-B-HA
composites. The results indicate that the optimal ratio between the polymer and the
ceramic is important in improving the mechanical properties, particularly the mechanical
strengths. The composite will allow us to modify the mechanical properties by optimizing
the molecular weights and the ratio of the polymer to the ceramic incorporated during the
fabrication process.

4.2.5 Bioactivity evaluation
4.2.5.1 Alkaline phosphatase assay
Alkaline phosphatase activity is a characteristic marker of early osteoblastic
differentiation. We have analyzed the alkaline phosphatase activity of bone marrow stem
cells cultured on to 1:1, 1:2, 1:3 PLGA-B-HA composites and control samples incubated
in polystyrene dishes immersed in tissue culture media over a period of 10, 20 and 30
days. A significant difference (n = 4, p < 0.05) in the AP activity of 1:3 over 1:1 and 1:2
PLGA-B-HA composites at the end of the 30-day period whereas no significant
difference (p > 0.05) were observed at the end of 10 and 20 days (Fig. 28). Protein
concentration (µg/ml) indicates no significant difference (p > 0.05) secreted by the rat
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marrow stem cells on 1:1, 1:2 and 1:3 PLGA-B-HA composites at the end of 30 days
(Fig. 27).

Tiffitt et al. showed the alkaline phosphatase staining demonstrated stimulation of this
marker of the osteogenic phenotype in the cultures grown with the cements compared
with human bone marrow stem cells cultured on plastic alone [79]. The results indicated
that alkaline phosphatase produced by cells increased significantly when grown in the
presence of calcium phosphate cements. Enzyme expression was increased in cells in
contact with the surface of the carbonated apatite and 90% hydroxyapatite cements as
compared to cells grown on plastic alone.

4.2.5.2 Osteocalcin
Osteocalcin or BGP (bone gla protein) is exclusively found in bone tissue. It accounts for
10-20% of the non-collagenous protein in bone. While the in vivo function of osteocalcin
is unknown, its affinity for bone mineral constituents implies a role in bone formation
[80]. It is a characteristic marker of bone forming cells i.e. osteoblasts. Cells attached on
to the surface of 1:3 PLGA-B-HA composites produced significantly higher osteocalcin
as compared to 1:1 and 1:2 composites (Fig. 32). Also, here we could observe the cells
produced osteocalcin at a relatively shorter period i.e. 14 days of time on the 1:3 as
compared to 1:2 and 1:1 PLGA-B-HA composites respectively (Fig. 30). Cells produced
higher osteocalcin on 1:2 PLGA-B-HA composites at the end of 28 days. At the end of
28 days we could observe a significant decrease (p < 0.05) in the osteocalcin
concentration in 1:3 PLGA-B-HA composites. No significant difference (p < 0.05) in the
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osteocalcin concentrations could be observed on 1:1 PLGA-B-HA composites and cells
incubated in polystyrene dishes at the end of 28 days respectively.

Figure 32. Indicates the osteocalcin concentration on 1:3 PLGA-B-HA composites at a
relatively short period of time as compared to 1:1, 1:2 PLGA-B-HA composites and
control samples at the end of 14, 21 and 28 days respectively.

Osteocalcin concentration produced by the cells on to 1:3 is significantly higher at the
end of 14 days as compared to 1:2 and 1:1 PLGA-B-HA composites. Cells seeded on to
1:3 PLGA-B-HA composites secreted higher osteocalcin and at a shorter period of time
as compared to 1:2 and 1:1 PLGA-B-HA composites (Fig.32). Also cells seeded on to 1:2
PLGA-B-HA composites secreted higher osteocalcin at the end of 21 days whereas no
increase in osteocalcin could be observed for the cells seeded on to 1:1 and cells cultured
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in polystyrene dishes at the end of 30 days respectively. Hence it could be inferred that a
higher ceramic (B-HA) concentration stimulates osteoblastic differentiation. Ma et al.
studied the synthesis of highly porous biodegradable polymer-hydroxyapatite scaffolds.
The results indicated that HA is osteoconductive and porous PLLA/HA scaffolds are
superior to pure PLLA scaffolds for bone tissue engineering [43]. Cellular activity was
determined using osteocalcin and bone sialoprotein measurements in tissue culture
medium followed by DNA assay analysis. The osteocalcin concentration produced by the
cells was high on to PLLA/HA scaffolds as compared to the PLLA scaffolds at the end of
6 weeks. In our study the results indicated, higher ceramic concentration as in the case of
1:3 PLGA-B-HA composite stimulated osteocalcin secretion at the end of 14 days. This
indicates stimulation of osteoblast function at an earlier time period which is due to the
increase in bovine hydroxyapatite concentration in the composite material.

4.2.6 Corrosion studies in tissue culture medium
ICP analyses indicate a minimal difference in Ca and P concentrations from 1:1, 1:2, 1:3
PLGA-B-HA composites and control samples incubated in polystyrene dishes (p > 0.05)
at the end of 7, 14, 21 and 28 days respectively (Fig. 30 and Fig. 31). From this we can
infer that there was a minimal difference in the dissolution/precipitation of Ca and P from
the degradation of PLGA-B-HA composites and that secreted from the osteoblasts. This
also indicates that the concentration of Ca and P due to the degradation of PLGA-B-HA
composite was similar to the Ca and P concentration produced by the activity of the bone
marrow stem cells. Hence the presence of the PLGA-B-HA composite did not affect the
ionic concentration of Ca and P.
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The corrosion products of the material can deteriorate the cell activity due its toxicity
effect or the adverse effect on pH. An increase or decrease in the environmental pH could
be unfavorable to the cells and could hinder cell attachment and hence bone formation.
The ideal pH value for tissue culture medium at 370C is 7.4. The pH values were
measured at 25.20C. No significant difference in pH was observed at the end of and 28
days for PLGA-B-HA composites and control samples respectively (Table 5). Most
importantly no significant difference (p > 0.05) could be observed in pH values for 1:1,
1:2, 1:3 PLGA-B-HA composites and control samples incubated in polystyrene culture
dishes at the end of 28 days were observed. Hence the presence of the composite did not
affect the pH of the surrounding environment.
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CHAPTER FIVE
CONCLUSIONS

1. We have engineered a novel porous B-HA-polymer ceramic composite and
correlated the effect of an increase in ceramic concentration on to stimulation of
mesenchymal stem cells to restrict to osteoblastic phenotypes.
2. PLGA-B-HA composites were highly porous with an interconnected porous
network which enhanced cell colonization.
3. Composites with high ceramic concentration induced osteoblast differentiation as
indicated by high AP activity, high osteocalcin concentration, and mineralized
extracellular matrix formation.
4. Increased surface roughness enhances cellular activity as indicated by 1:3 PLGAB-HA composites.
5. The presence of the PLGA-B-HA composite did not affect the ionic concentration
of Ca and P and the surrounding pH.
6. A variation in the chemical composition affected the cellular activity of
osteoblasts.
7. An increase in ceramic concentration stimulated osteoblast function.
8. PLGA-B-HA can serve as a suitable carrier for the delivery for BMSC’s.
9. Use of bovine hydroxyapatite may induce higher bioactivity than other forms of
hydroxyapatite.
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FUTURE WORK

The composites would be immersed in SBF to determine the bioactivity via ion
exchange mechanisms. The total DNA content of the cells seeded on to 1:3 PLGA-BHA composites would be analyzed and the results would be compared with 1:1 and
1:2 PLGA-B-HA composites. In vivo analysis would include subcutaneous
implantation of macroporous, bioactive, 1:3 PLGA-B-HA composites loaded with
bone marrow cells in rats.
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